BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. (Q40695052)
Jump to navigation
Jump to search
scientific article published on 18 July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. |
scientific article published on 18 July 2002 |
Statements
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin (English)
Matthias Mayerhofer
Wolfgang R Sperr
James D Griffin
Christian Sillaber